No Data
Expectations for the progress of the weak yen and tariff negotiations are driving prices close to 37,000 yen.
The Nikkei average has risen for seven consecutive trading days, finishing at 36,830.69 yen, up 378.39 yen (with an estimated volume of 1.9 billion 70 million shares). The depreciation of the yen, driven by the retreat of speculation regarding additional interest rate hikes by the Bank of Japan, combined with expectations of progress in tariff discussions with the USA, led to a bullish start. Autos stocks were bought, reaching as high as 36,976.51 yen in the middle of the morning session, approaching the significant level of 37,000 yen. However, ahead of the four-day holiday, profit-taking selling is likely to occur, and the USA is awaiting the announcement of the employment statistics for April.
The Nikkei average is about 230 yen higher, with positive contributions from Fast Retailing, Daikin, and Shin-Etsu Chemical leading the way.
At 12:47 PM on the 2nd, the Nikkei Stock Average is trending around 36,680 yen, up about 230 yen from the previous day. In the afternoon session, trading started near the morning's closing price. After that, it seems that active trading is limited due to the upcoming consecutive holidays. The foreign exchange market is at 145.20 yen to the dollar, and the yen is strengthening in the afternoon. In terms of the contributions of the stocks included in the Nikkei Stock Average, Fast Retailing <9983.T>, Daikin <6367.T>, and Shin-Etsu Chemical <4063.T> rank among the top positives.
The ADR trends for the day = In yen conversion, TDK, Advantest, Kyocera Corporation Sponsored ADR, etc. are high.
The American Depositary Receipts (ADRs) for the day, when converted to yen, were universally higher compared to the closing prices in Tokyo. In yen terms, TDK <6762.T>, Advantest <6857.T>, Kyocera Corporation Sponsored ADR <6971.T>, Nissan Motor <7201.T>, and Mizuho <8411.T> were higher. Kirin Holdings <2503.T>, Shin-Etsu Chemical <4063.T>, Kubota <6326.T>, Kawasaki Heavy Industries <7012.T>, and SoftBank Group <9984.T> were also higher. Provided by Wealth Advisor Co.
After the delayed interest rate hike by the Bank of Japan, the Nikkei average stock price temporarily recovered to 36,500 yen.
The Nikkei average continued to rise significantly for six consecutive trading days, closing up 406.92 yen at 36,452.30 yen (Volume estimated at 1.8 billion 60 million shares). Amid the sharp surge in the after-hours trading of U.S. Microsoft and Meta Platforms Inc, buying started to lead in the Tokyo market, particularly in the Semiconductors sector. Additionally, the depreciation of the yen to the 144 yen level against the dollar following the announcement of the Bank of Japan's monetary policy decision was also viewed as favorable, increasing the number of export-related stocks that gained in value.
The index has recovered to the 36,000 yen range for the first time in a month.
The Nikkei average has risen for five consecutive trading days. It ended with a gain of 205.39 yen at 36,045.38 yen (with an estimated Volume of 2.2 billion 80 million shares), recovering the 36,000 yen mark for the first time in about a month. Increased expectations for a rise due to the strong US stock market and progress in US tariff negotiations led the buying. The Nikkei average briefly returned above 36,000 yen right after trading began. However, as it surpassed the key level of 36,000 yen, opposing sentiments emerged, and gradually a wait-and-see mood spread, resulting in consolidation around 35,900 yen. Toward the end of the afternoon session, index buying is expected from pension funds at the end of the month.
Stocks that moved and those that were traded in the front market.
* Komatsu Wall <7949> 1780 - The significant increase in the dividend plan raises the appeal of the yield. * Sumitomo Pharma <4506> 787 +100 The substantial upward revision beyond expectations has an impact. * Square Enix HD <9684> 8121 +993 3D Investment emerged as a major shareholder. * S.M.S <2175> 1360 +168 The forecast of double-digit profit growth this period and the strengthening of shareholder returns are well received. * Genky Drug Stores <9267> 3630 +42
